Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chinese Medical Journal

• Publication date

  2009-09-05

• Fields of study

  Medicine

• Identifiers
  PMID 19781383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD58 expression of liver tissue in patients with chronic hepatitis B virus infection.

  2008cited by this paper
• Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies.

  2006cited by this paper
• Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)

  2006cited by this paper
• Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

  2006cited by this paper
• Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.

  2004cited by this paper
• Anti-Angiogenic Activity of a Homoisoflavanone from cremastra appendiculata

  2004cited by this paper
• Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial

  2004cited by this paper
• Chemoembolization for hepatocellular carcinoma.

  2004cited by this paper
• Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey

  2004cited by this paper
• Classification of isolated tumor cells

  2003cited by this paper
• Hepatocellular carcinoma

  2003cited by this paper
• Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

  2003cited by this paper
• Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

  2002cited by this paper
• Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective

  2002cited by this paper
• Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

  2002cited by this paper
• Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma

  2001cited by this paper
• Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.

  2000cited by this paper
• Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival

  2000cited by this paper
• Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.

  2000cited by this paper
• Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma

  2000cited by this paper
• Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

  2000cited by this paper
• Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.

  1999cited by this paper
• Percutaneous Radiofrequency Thermal Ablation Combined with Transcatheter Arterial Embolization in the Treatment of Large Hepatocellular Carcinoma

  1999cited by this paper
• Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.

  1995cited by this paper
• Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management.

  1995cited by this paper
• Immunomodulatory and Anti-Tumour Polysaccharides from Medicinal Plants

  1994cited by this paper

• Mechanism of Jiedu Prescription in Hepatocellular Carcinoma: Integrating Network Pharmacology and Experimental Validation

  2025cites this paper
• Efficacy of Jiedu formula as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery: a propensity score matching study.

  2025cites this paper
• Inhibition Effect of Dictyophora Polysaccharides on Human Hepatocellular Carcinoma Cell Line HCC-LM3

  2020cites this paper
• Genus: Bletilla to Bulbophyllum

  2016cites this paper
• Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma

  2016cites this paper
• Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization.

  2014cites this paper
• Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalities.

  2013cites this paper
• Phenanthrenes, 9,10-dihydrophenanthrenes, bibenzyls with their derivatives, and malate or tartrate benzyl ester glucosides from tubers of Cremastra appendiculata.

  2013cites this paper
• Efficacy and safety of transcatheter chemoembolization of the internal thoracic artery in patients with hepatocellular carcinoma.

  2011cites this paper